DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Chang M, Yu Z, Shenker A. et al.
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban.
J Clin Pharmacol 2016;
56 (05) 637-645
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.